17 November 2021
Genomic data promises incredible insights into disease risks, but careful frameworks are needed to properly manage its use.
Being told you are genetically predisposed to disease is scary – what does it even mean? Genetics and disease are highly complex and this often means it is hard to navigate whether there is high risk of disease or not. Beyond this, our genetic data can feel personal. So how do we ensure our genetic data is translated responsibly by healthcare providers?
Cosmos spoke to molecular geneticist Dr Fayeza Khan and Professor Michael Inouye, director of the Cambridge Baker Systems Genomics Initiative and Munz Chair of Cardiovascular Prediction and Prevention, Baker Heart and Diabetes Institute, about the complex biology and ethics of genetic disease.
Read the full article on the COSMOS website.
Stay on top of the latest findings with our newsletterSubscribe